Clinical Trial Update: Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating OZURDEX in macular edema due to retinal vein occlusion in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Allergan | Conditions: Macular Edema, Retinal Vein Occlusion | Phase 4 | Status: COMPLETED